Federal and state health care regulation
Regulatory Exposure
Substantial level of government regulation over the business; new or changed laws can materially affect operations.
Relevance 95·Dependency 90·Confidence 95
Source evidence
“the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations”
Pharmacy Benefit Services
Revenue Exposure
Pharmacy Benefit Services is one of two operating segments of Evernorth Health Services, a core revenue-generating business line.
Relevance 90·Dependency 85·Confidence 95
Source evidence
“Evernorth Health Services includes our Pharmacy Benefit Services and Specialty and Care Services operating segments”
Cigna Healthcare
Revenue Exposure
Cigna Healthcare is the health benefits segment providing medical solutions via U.S. Healthcare and International Health operating segments.
Relevance 90·Dependency 85·Confidence 95
Source evidence
“Cigna Healthcare, the health benefits segment of The Cigna Group, provides comprehensive medical and coordinated solutions”
Pharmacy claims processing platform
Technology Dependency
Uninterrupted point-of-sale electronic retail pharmacy claims processing is a significant operational requirement; platform adjudicates over two billion prescriptions annually.
Relevance 90·Dependency 85·Confidence 90
Source evidence
“uninterrupted point-of-sale electronic retail pharmacy claims processing is a significant operational requirement for our business”
Key pharmaceutical manufacturers
Supplier Dependency
Business depends on relationships with key pharmaceutical manufacturers and payments/discounts they provide; declines could hurt results.
Relevance 90·Dependency 85·Confidence 90
Source evidence
“our ability to maintain relationships with one or more key pharmaceutical manufacturers or if payments made or discounts provided decline”
Pharmaceutical manufacturers
Supplier Dependency
Pharma manufacturers supply rebates, discounts and specialty distribution access; loss or decline of payments would adversely affect results.
Relevance 88·Dependency 80·Confidence 90
Source evidence
“If we lose our relationship with one or more key pharmaceutical manufacturers, or if the payments made or discounts provided by pharmaceutical manufacturers decline, our business and results of operations could be adversely affected.”
Specialty and Care Services
Revenue Exposure
Specialty and Care Services is the second Evernorth operating segment, providing coordinated health solutions.
Relevance 85·Dependency 80·Confidence 92
Source evidence
“through our Pharmacy Benefit Services and Specialty and Care Services operating segments”
Pharmacy provider networks
Supplier Dependency
Changes in the pharmacy provider marketplace or pharmacy networks pose operational and financial risk.
Relevance 85·Dependency 80·Confidence 90
Source evidence
“changes in the pharmacy provider marketplace or pharmacy networks”
Large employer clients
Revenue Exposure
Large clients can easily move between competitors; termination or renegotiation of large client contracts would adversely affect results.
Relevance 85·Dependency 75·Confidence 90
Source evidence
“If one or more of our large clients terminates or does not renew a contract for any reason, or if the provisions of a contract with a large client are modified with terms less favorable to us, our results of operations could be adversely affected”
Inflation Reduction Act
Regulatory Exposure
IRA grants CMS power to negotiate high-cost Medicare drug prices, affecting drug pricing strategy and which medications are prioritized.
Relevance 82·Dependency 55·Confidence 92
Source evidence
“laws such as the Inflation Reduction Act have granted CMS the ability to negotiate drug prices for high-cost Medicare Part D and Part B drugs”
Pharmaceutical manufacturer rebates
Supplier Dependency
Rebate value guaranteed to clients depends on negotiations with pharmaceutical manufacturers; Express Scripts may bear rebate-value risk.
Relevance 80·Dependency 75·Confidence 90
Source evidence
“The actual amount of value secured by Express Scripts is dependent upon the result of its negotiations for rebates.”
Inflationary and interest rate pressures
Cost Driver
Inflation and interest rate pressures could compress margins or make premiums insufficient to cover cost of services.
Relevance 80·Dependency 70·Confidence 90
Source evidence
“inflation and other pressures that could compress our margins or result in premiums that are insufficient to cover the cost of services delivered to our customers”
Artificial intelligence / machine learning
Technology Dependency
AI/ML supports product development and health care transformation but introduces risks; governed by EMG and Responsible AI Principles.
Relevance 80·Dependency 70·Confidence 85
Source evidence
“We use artificial intelligence ("AI") to support health care transformation by helping to enable the next generation of accessible, effective, affordable and enhanced health care solutions.”
Change Healthcare (UnitedHealth Group)
Supplier Dependency
Change Healthcare is a service provider for certain PBM services; its February 2024 ransomware attack caused limited service disruption.
Relevance 78·Dependency 65·Confidence 93
Source evidence
“a service provider for certain of our pharmacy benefit management services, was the victim of a ransomware attack in February 2024. This resulted in limited disruption of certain of our services”
Retail pharmacy network
Supplier Dependency
Company contracts with retail pharmacies across the US to dispense prescriptions and negotiates price discounts for network options.
Relevance 75·Dependency 70·Confidence 90
Source evidence
“We contract with retail pharmacies to provide prescription drugs to customers of the pharmacy benefit plans our clients offer.”
Health services competitors
Competitive Exposure
Ability to compete effectively, differentiate products/services and adapt to a rapidly evolving industry is a key uncertainty.
Relevance 75·Dependency 65·Confidence 85
Source evidence
“our ability to compete effectively, differentiate our products and services from those of our competitors and adapt to changes in an evolving and rapidly changing industry”
Pharmacy rebate regulation
Competitive Exposure
Legislative reforms and regulatory actions related to rebates, reporting, and owned pharmacies may impair ability to price pharmacy products and services appropriately.
Relevance 75·Dependency 60·Confidence 85
Source evidence
“legislative reforms and regulatory or executive actions related to rebates, reporting, owned pharmacies and other activities may adversely affect our ability to price our pharmacy products and services appropriately”
Health care costs affected by external events including inflation, pandemics, natural disasters, and changes in utilization patterns.
Relevance 72·Dependency 50·Confidence 88
Source evidence
“provider billing practices, inflation and changes in customers' health care utilization patterns, pandemics, natural disasters, and other large-scale medical emergencies.”
Economic downturn / employment metrics
Revenue Exposure
Recession or economic downturn could affect employment metrics, which drive insured membership and revenue.
Relevance 70·Dependency 60·Confidence 85
Source evidence
“unfavorable economic and market conditions, the risk of a recession or other economic downturn and resulting impact on employment metrics, stock market or changes in interest rates”
Integrated pharmacy benefit clients
Demand Driver
Rebate economics and client relationships drive pharmacy benefit services revenue; most clients choose rebate guarantees.
Relevance 70·Dependency 60·Confidence 85
Source evidence
“with most choosing to receive the greater of a minimum rebate guarantee or a contractually agreed-upon percentage of rebates”
Artificial intelligence / machine learning
Technology Dependency
AI/ML use creates regulatory and legal challenges including generative AI hallucination and bias risks; cyber threats also enhanced by AI.
Relevance 70·Dependency 55·Confidence 88
Source evidence
“Our use of AI and ML technologies, as well as more recent technological advances in AI/ML, pose risks to us and subject us to new and existing laws and regulations.”
Healthcare affordability and transparency pressure
Demand Driver
Company strategy centers on affordability and transparency, including a rebate-free model adoption timeline, reflecting industry pressure.
Relevance 70·Dependency 50·Confidence 75
Source evidence
“Evernorth Health Services has announced a transformative new pharmacy benefits model to make discounts negotiated with drug companies available upfront to customers buying their medications”
Potential $1.2 billion future tax payments if uncertain tax positions are not sustained, though adequately reserved.
Relevance 70·Dependency 50·Confidence 93
Source evidence
“it could result in future tax payments of approximately $1.2 billion. We are adequately reserved for such positions.”
Brokers and benefit consultants
Customer Exposure
Brokers and consultants influence client decisions and may take on services Cigna typically provides, threatening revenue.
Relevance 65·Dependency 55·Confidence 87
Source evidence
“as brokers and benefit consultants seek to enhance their revenue streams, they look to take on services that we typically provide.”
interest rates
Currency Exposure
Rising cost of capital could adversely affect goodwill and intangible impairment evaluations given $44.9B goodwill balance.
Relevance 55·Dependency 45·Confidence 85
Source evidence
“If we consistently do not achieve our earnings and cash flow projections or our cost of capital rises significantly, the assumptions and estimates underlying the goodwill and intangible asset impairment evaluations could be adversely affected and result in future impairment charges”